Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an investigator initiated, sponsored, open label, prospective randomized controlled trial to be performed in adult patients undergoing scheduled cardiac surgery. Patients will be randomized to esmolol infusion or nitroglycerin infusion for control of hypertension that occurs during cardiac surgery from induction of anesthesia to initiation of cardiopulmonary bypass (CPB).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loma Linda University
• Treatments: Esmolol; Nitroglycerin

Criteria

Inclusion Criteria:

• adult patients scheduled for cardiac surgery at LLUMC University Hospital will be eligible for participation in this study.

Exclusion Criteria:

1. severe LV (left ventricle)dysfunction (EF < 35%).

2. emergency procedures.

3. procedures with combined carotid artery surgery.

4. patients at high risk for stroke.

5. hemodynamically significant dysrhythmias.

6. pre-existing atrial fibrillation or high degree AV (atrioventricular block).

7. pacemaker dependency.

8. known sensitivity to beta blockers.

9. patient refusal.